SCAPER localizes to primary cilia and its mutation affects cilia length, causing Bardet-Biedl syndrome.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
06 2019
Historique:
received: 03 05 2018
accepted: 04 01 2019
revised: 17 12 2018
pubmed: 7 2 2019
medline: 12 6 2020
entrez: 7 2 2019
Statut: ppublish

Résumé

Studies of ciliopathies have served in elucidating much of our knowledge of structure and function of primary cilia. We report humans with Bardet-Biedl syndrome who display intellectual disability, retinitis pigmentosa, obesity, short stature and brachydactyly, stemming from a homozyogous truncation mutation in SCAPER, a gene previously associated with mitotic progression. Our findings, based on linkage analysis and exome sequencing studies of two remotely related large consanguineous families, are in line with recent reports of SCAPER variants associated with intellectual disability and retinitis pigmentosa. Using immuno-fluorescence and live cell imaging in NIH/3T3 fibroblasts and SH-SY5Y neuroblastoma cell lines over-expressing SCAPER, we demonstrate that both wild type and mutant SCAPER are expressed in primary cilia and co-localize with tubulin, forming bundles of microtubules. While wild type SCAPER was rarely localized along the ciliary axoneme and basal body, the aberrant protein remained sequestered to the cilia, mostly at the ciliary tip. Notably, longer cilia were demonstrated both in human affected fibroblasts compared to controls, as well as in NIH/3T3 cells transfected with mutant versus wildtype SCAPER. As SCAPER expression is known to peak at late G1 and S phase, overlapping the timing of ciliary resorption, our data suggest a possible role of SCAPER in ciliary dynamics and disassembly, also affecting microtubule-related mitotic progression. Thus, we outline a human ciliopathy syndrome and demonstrate that it is caused by a mutation in SCAPER, affecting primary cilia.

Identifiants

pubmed: 30723319
doi: 10.1038/s41431-019-0347-z
pii: 10.1038/s41431-019-0347-z
pmc: PMC6777442
doi:

Substances chimiques

Carrier Proteins 0
SCAPER protein, human 0

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

928-940

Références

EMBO J. 2010 Oct 6;29(19):3344-57
pubmed: 20818332
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W593-9
pubmed: 19465395
Heredity (Edinb). 2014 Feb;112(2):182-9
pubmed: 24084643
Bioinformatics. 2013 Jan 15;29(2):197-205
pubmed: 23162081
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Nat Cell Biol. 1999 Jun;1(2):88-93
pubmed: 10559879
Nat Cell Biol. 2014 Jul;16(7):663-72
pubmed: 24952464
Oncogene. 2008 Jul 17;27(31):4261-8
pubmed: 18372919
Eur J Hum Genet. 2017 Aug;25(8):966-972
pubmed: 28488683
Science. 2007 Apr 20;316(5823):417-21
pubmed: 17412918
Nature. 2011 Sep 21;478(7367):57-63
pubmed: 21937992
Nature. 2014 May 29;509(7502):575-81
pubmed: 24870542
Cilia. 2014 Nov 17;3:9
pubmed: 25422781
Cell Cycle. 2008 Mar 15;7(6):702-5
pubmed: 18245951
J Cell Biol. 2007 Aug 13;178(4):621-33
pubmed: 17698606
Hum Genet. 2016 Jun;135(6):615-23
pubmed: 27068822
Cell. 2015 Oct 22;163(3):712-23
pubmed: 26496610
Pediatr Nephrol. 2011 Jul;26(7):1039-56
pubmed: 21210154
Hum Mutat. 2013 Apr;34(4):582-6
pubmed: 23316006
Nat Genet. 2001 Jun;28(2):188-91
pubmed: 11381270
Nature. 2014 May 29;509(7502):582-7
pubmed: 24870543
Hum Mol Genet. 2016 Jun 1;25(11):2283-2294
pubmed: 27008867
Mol Biol Cell. 2013 Sep;24(18):2894-906
pubmed: 23885124
Ophthalmic Genet. 2016 Sep;37(3):290-3
pubmed: 26854863
J Biol Chem. 2011 Nov 4;286(44):38602-13
pubmed: 21880733
Mol Cell Proteomics. 2007 Aug;6(8):1299-317
pubmed: 17494944
Methods Cell Biol. 2009;94:137-60
pubmed: 20362089
J Med Genet. 2017 Aug 9;54(10):698-704
pubmed: 28794130
J Vis Exp. 2013 Jul 07;(77):e3779
pubmed: 23852182
Nat Genet. 2010 Jan;42(1):36-44
pubmed: 20010834
Mol Biol Cell. 2014 Nov 15;25(23):3740-8
pubmed: 25232011
J Clin Invest. 2009 Mar;119(3):428-37
pubmed: 19252258
J Med Genet. 1999 Jun;36(6):437-46
pubmed: 10874630
Nat Rev Mol Cell Biol. 2011 Oct 12;12(11):709-21
pubmed: 21993292
Am J Hum Genet. 2016 Aug 4;99(2):318-36
pubmed: 27486776
Nat Cell Biol. 2016 Jun 28;18(7):711-7
pubmed: 27350441
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Intelligence. 2016 Jan-Feb;54:80-89
pubmed: 26912939
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Am J Hum Genet. 2017 Jan 5;100(1):75-90
pubmed: 28041643
Clin Genet. 1988 Feb;33(2):78-82
pubmed: 3359670
Nat Rev Mol Cell Biol. 2017 Sep;18(9):533-547
pubmed: 28698599
Nat Genet. 2016 Aug;48(8):877-87
pubmed: 27399968
J Community Genet. 2014 Oct;5(4):395-8
pubmed: 24816554

Auteurs

Ohad Wormser (O)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.

Libe Gradstein (L)

Department of Ophthalmology, Soroka Medical Center and Clalit Health Services, Faculty of Health Sciences, Ben-Gurion University, 84101, Beer Sheva, Israel.

Yuval Yogev (Y)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.

Yonatan Perez (Y)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.

Rotem Kadir (R)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.

Inna Goliand (I)

Department of Life Sciences and National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, 84105, Beer Sheva, Israel.

Yair Sadka (Y)

Child Developmental Center, Beer Sheva Mental Health Center, Ben-Gurion University of the Negev, 84101, Beer Sheva, Israel.

Saad El Riati (S)

Clalit Health Services, Southern district, P.O. Box 616, 30 Itzhak Rager Street, Beer sheva, Israel.

Hagit Flusser (H)

The Zusman Institute for Child Development, Division of Pediatrics, Soroka Medical Center and Ben-Gurion University of the Negev, 84101, Beer Sheva, Israel.

Dikla Nachmias (D)

Department of Life Sciences and National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, 84105, Beer Sheva, Israel.

Ruth Birk (R)

Department of Nutrition, Faculty of Health Sciences, Ariel University, Ariel, Israel.

Muhamad Iraqi (M)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.

Einat Kadar (E)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.

Roni Gat (R)

Department of Life Sciences and National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, 84105, Beer Sheva, Israel.

Max Drabkin (M)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.

Daniel Halperin (D)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.

Amir Horev (A)

Department of Dermatology and Venereology and Division of Pediatrics, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101, Beer Sheva, Israel.

Sara Sivan (S)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.

Uri Abdu (U)

Department of Life Sciences, Ben-Gurion University, 84105, Beer Sheva, Israel.

Natalie Elia (N)

Department of Life Sciences and National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, 84105, Beer Sheva, Israel.

Ohad S Birk (OS)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel. obirk@bgu.ac.il.
Genetics Institute, Soroka Medical Center, Ben-Gurion University of the Negev, 84101, Beer Sheva, Israel. obirk@bgu.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH